Director exercised or converted 25K GMED derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jun 5, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jun 9, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001193125-26-263997
Filed / recordedJun 9, 2026, 9:04 PM UTCAdded to OQROOct 6, 2026, 7:37 PM UTC Data qualityVerified: identifiers matched exactly Reporting personDavid D Davidar SecurityStock Option (Right to Buy Class A Common Stock) TableDerivative (Table II) Transaction dateJun 5, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- These options were granted on January 30, 2017 and are fully vested.
Around the same time
Derivative exercise or conversion — not an open-market buy.
A board member of Globus Medical sold $2.02M of Globus Medical shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.